This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International
September 22-25, 2026 as part of Biotech Week Boston
Hynes Convention CenterBoston, MA
Book Now
Menu
Book
Key Sessions
Nelly Viseux
Keynote: Journey from R&D to Clinical Manufacturing
Regeneron
Robert Hofmeister
Keynote: Programming Immunity In Vivo: Targeted RNA–LNP Platforms for Precision CAR Engineering
CREATE Medicines
Silviu Itescu
Keynote Presentation: Lessons Learnt of the Path to Commercialisation
Mesoblast
Therese Choquette
Panel Discussion: Decentralized Manufacturing in Cell Therapy: Overcoming Implementation Challenges and Enhancing Patient-Centric Solutions
Tigen Pharma SA
keyboard_arrow_right

Friday 25th September - Conference Day Three - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Friday 25th September - Conference Day Three - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
8:25am - 8:50am
Registration & Morning Coffee
Showing 3 of 3 Streams
8:50am - 9:00am
Chairperson’s Opening Remarks: Development of Emerging Cell & Gene Therapies
9:00am - 9:30am
Keynote: Journey from R&D to Clinical Manufacturing
  • Nelly Viseux - Vice President, Cell Therapies Development, Manufacturing, Supply & Quality, Regeneron
9:30am - 10:00am
Keynote: Programming Immunity In Vivo: Targeted RNA–LNP Platforms for Precision CAR Engineering
  • Robert Hofmeister - Chief Scientific Officer, CREATE Medicines
10:00am - 10:30am
Moving Gene Editing Beyond the Liver
  • Devyn M. Smith - Chief Executive Officer, Arbor Biotechnologies
8:50am - 9:00am
Chairperson’s Opening Remarks: Cell Therapy Manufacturing & Analytics
9:00am - 9:30am
Panel Discussion: Decentralized Manufacturing in Cell Therapy: Overcoming Implementation Challenges and Enhancing Patient-Centric Solutions
  • Therese Choquette - Chief Technical Officer, Tigen Pharma SA
  • Thorsten Gorba - VP, Process & Analytical Development, Aspen Neuroscience, Inc.
  • Tatyana Matveeva - Director of cGMP Operations, Regenerative Cell Therapy, Massachusetts General Hospital and Harvard Medical School
9:30am - 10:00am
Enabling sgRNA Release and Stability Testing with a ddPCR-Based Potency Assay
  • Hugh Gannon - Associate Director, KSQ Therapeutics
10:00am - 10:30am
Sponsored Scientific Track Presentation: Application and Validation of Rapid Cell Analytical Technologies for Product Release at Scale

Spotlight Presentation – Calling all Technology Thought Leaders!


This session is your platform to demonstrate leadership and technical expertise. Present your data, case studies, and innovative solutions to a targeted audience of senior scientists and engineers looking to solve hurdles in their production processes.

To learn more about sponsoring this session, contact us at Partners@informaconnectls.com

8:50am - 9:00am
Chairperson’s Opening Remarks: Gene Therapy Manufacturing & Analytics
9:00am - 9:30am
Keynote Panel Discussion: Navigating BLA Success - Strategies for Streamlined Gene Therapy Approval Success
  • Tiffany D Rau, PhD - Principal Consultant BioPharma Technical Consulting and Rau Consulting, Adjunct Professor Biochemistry and Cell Biology, University College Cork, Ireland
9:30am - 10:00am
From Vial to Brain: Demonstrating AAV Gene Therapy Stability During Convection-Enhanced Delivery
  • Nathalie Clement - SVP, Vector Development, Siren Biotechnology
10:00am - 10:30am
Sponsored Scientific Track Presentation

Spotlight Presentation – Calling all Technology Thought Leaders!


This session is your platform to demonstrate leadership and technical expertise. Present your data, case studies, and innovative solutions to a targeted audience of senior scientists and engineers looking to solve hurdles in their production processes.

To learn more about sponsoring this session, contact us at Partners@informaconnectls.com

Showing 1 of 1 Streams
10:30am - 11:15am
Networking Refreshment Break in the Exhibit Hall
Showing 3 of 3 Streams
11:15am - 11:30am
Development of Next Generation Cell Therapies for Autoimmune Disease
  • Mayo Pujols - CTO, Kyverna
11:30am - 11:45am
The Siren Experience: Advancing SRN-101 for High Grade Gliomas
  • Lauren Kelly - Director of Translational Research, Siren Biotechnology
11:45am - 12:00pm
Gene Therapy for Immune Reprogramming and the Treatment of Inflammatory Diseases
  • Shahrooz Rabizadeh - CEO & Co-Founder, Sagittarius Bio, Inc
12:00pm - 12:15pm
Case Studies: Development of Next-Gen Cell & Gene Therapies – Overcoming Challenges and Breakthroughs
12:15pm - 12:45pm
Sponsored Scientific Track Presentation

Spotlight Presentation – Calling all Technology Thought Leaders!

This session is your platform to demonstrate leadership and technical expertise. Present your data, case studies, and innovative solutions to a targeted audience of senior scientists and engineers looking to solve hurdles in their production processes.

To learn more about sponsoring this session, contact us at Partners@informaconnectls.com

11:15am - 11:45am
Culture and Non-Culture-Based Approaches to Cell Therapy Potency
  • Ronnie Lum - Director Analytical Development, Analytical and Quality Control, BlueRock Therapeutics
11:45am - 12:15pm
Progress toward Standards and Reference Materials for Cell Viability
  • Laura Pierce - Biomedical Engineer, NIST
12:15pm - 12:45pm
Sponsored Scientific Track Presentation: Latest Advances in Cryopreservation Techniques and Maintaining Cell Viability at Scale

Spotlight Presentation – Calling all Technology Thought Leaders!

This session is your platform to demonstrate leadership and technical expertise. Present your data, case studies, and innovative solutions to a targeted audience of senior scientists and engineers looking to solve hurdles in their production processes.

To learn more about sponsoring this session, contact us at Partners@informaconnectls.com

11:15am - 11:45am
Characterizing Adeno-associated viruses (AAV) by Micro-Electrophoresis
  • Rishi Kothari - Process Development Engineer, Regeneron Pharmaceuticals
11:45am - 12:15pm
Machine Learning and Mechanistic Modeling Approaches Within Upstream Process Development to Improve AAV Product Quality
  • Neil Templeton - Director, Upstream Process Development, Solid Biosciences
12:15pm - 12:35pm
Predictive Modeling and Process Interdependency: A Strategic Approach to Late-Stage AAV Purification Development
  • Chen Wang - Principal Scientist, GMU CMC Purification Process Development, Sanofi
Showing 1 of 1 Streams
12:45pm - 2:00pm
Lunch in the Exhibit Hall (Last Chance to Meet with Exhibitors)
Showing 1 of 1 Streams
2:00pm - 2:05pm
Chairperson’s Opening Remarks
2:05pm - 2:45pm
Keynote Patient Fire Side Chat: Amplifying Patient Voices- Patient Centric CGT Innovation
2:45pm - 3:30pm
Keynote Presentation: Lessons Learnt of the Path to Commercialisation
  • Silviu Itescu - CEO, Mesoblast
3:30pm - 3:35pm
Close of Event 2026 – See You Next Year!
Thursday 24th September - Conference Day Two
Filter
Streams
Choose Day